
Sign up to save your podcasts
Or


Beijing will let companies submit to U.S. audit requirements. In this Viewsroom podcast, Breakingviews columnists argue only weak firms will comply. Also, Pfizer and Moderna’s legal battle is unlikely to create a winner, and Britain’s prime ministerial hopefuls debate handouts.
Learn more about your ad choices. Visit megaphone.fm/adchoices
By Reuters4.2
4646 ratings
Beijing will let companies submit to U.S. audit requirements. In this Viewsroom podcast, Breakingviews columnists argue only weak firms will comply. Also, Pfizer and Moderna’s legal battle is unlikely to create a winner, and Britain’s prime ministerial hopefuls debate handouts.
Learn more about your ad choices. Visit megaphone.fm/adchoices

7,913 Listeners

4,225 Listeners

523 Listeners

4,420 Listeners

296 Listeners

427 Listeners

33 Listeners

686 Listeners

684 Listeners

1,089 Listeners

64 Listeners

302 Listeners

150 Listeners

146 Listeners

29 Listeners